Literature DB >> 26560803

The health status of a village population, 7 years after a major Q fever outbreak.

G Morroy1, W Van Der Hoek2, Z D Nanver1, P M Schneeberger3, C P Bleeker-Rovers4, J Van Der Velden5, R A Coutinho6.   

Abstract

From 2007 to 2010, The Netherlands experienced a major Q fever outbreak with more than 4000 notifications. Previous studies suggested that Q fever patients could suffer long-term post-infection health impairments, especially fatigue. Our objective was to assess the Coxiella burnetii antibody prevalence and health status including fatigue, and assess their interrelationship in Herpen, a high-incidence village, 7 years after the outbreak began. In 2014, we invited all 2161 adult inhabitants for a questionnaire and a C. burnetii indirect fluorescence antibody assay (IFA). The health status was measured with the Nijmegen Clinical Screening Instrument (NCSI), consisting of eight subdomains including fatigue. Of the 70·1% (1517/2161) participants, 33·8% (513/1517) were IFA positive. Of 147 participants who were IFA positive in 2007, 25 (17%) seroreverted and were now IFA negative. Not positive IFA status, but age <50 years, smoking and co-morbidity, were independent risk factors for fatigue. Notified participants reported significantly more often fatigue (31/49, 63%) than non-notified IFA-positive participants (150/451, 33%). Although fatigue is a common sequel after acute Q fever, in this community-based survey we found no difference in fatigue levels between participants with and without C. burnetii antibodies.

Entities:  

Keywords:  Coxiella burnetii; IFA; NCSI; Q fever; post-infection fatigue

Mesh:

Substances:

Year:  2015        PMID: 26560803     DOI: 10.1017/S0950268815002472

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  9 in total

Review 1.  From Q Fever to Coxiella burnetii Infection: a Paradigm Change.

Authors:  Carole Eldin; Cléa Mélenotte; Oleg Mediannikov; Eric Ghigo; Matthieu Million; Sophie Edouard; Jean-Louis Mege; Max Maurin; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  Coxiella burnetii Epitope-Specific T-Cell Responses in Patients with Chronic Q Fever.

Authors:  Ann E Sluder; Anja Garritsen; Anja Scholzen; Guilhem Richard; Leonard Moise; Eva Hartman; Chantal P Bleeker-Rovers; Patrick M Reeves; Susan Raju Paul; William D Martin; Anne S De Groot; Mark C Poznansky
Journal:  Infect Immun       Date:  2019-09-19       Impact factor: 3.441

3.  Natural Exposure- and Vaccination-Induced Profiles of Ex Vivo Whole Blood Cytokine Responses to Coxiella burnetii.

Authors:  Susan Raju Paul; Anja Scholzen; Ghazel Mukhtar; Stephanie Wilkinson; Peter Hobson; Richard K Dzeng; Jennifer Evans; Jennifer Robson; Rowland Cobbold; Stephen Graves; Mark C Poznansky; Anja Garritsen; Ann E Sluder
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

Review 4.  Q-vaxcelerate: A distributed development approach for a new Coxiella burnetii vaccine.

Authors:  Patrick M Reeves; Susan Raju Paul; Ann E Sluder; Timothy A Brauns; Mark C Poznansky
Journal:  Hum Vaccin Immunother       Date:  2017-09-21       Impact factor: 3.452

5.  Interferon-γ and CXCL10 responses related to complaints in patients with Q fever fatigue syndrome.

Authors:  Ruud P H Raijmakers; Anne F M Jansen; Stephan P Keijmel; Teske Schoffelen; Anja Scholzen; Jos W M van der Meer; Leo A B Joosten; Mihai G Netea; Marcel van Deuren; Chantal P Bleeker-Rovers
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-26       Impact factor: 3.267

6.  Promiscuous Coxiella burnetii CD4 Epitope Clusters Associated With Human Recall Responses Are Candidates for a Novel T-Cell Targeted Multi-Epitope Q Fever Vaccine.

Authors:  Anja Scholzen; Guilhem Richard; Leonard Moise; Laurie A Baeten; Patrick M Reeves; William D Martin; Timothy A Brauns; Christine M Boyle; Susan Raju Paul; Richard Bucala; Richard A Bowen; Anja Garritsen; Anne S De Groot; Ann E Sluder; Mark C Poznansky
Journal:  Front Immunol       Date:  2019-02-15       Impact factor: 7.561

7.  Long-term impact of a Q-fever outbreak: An evaluation of health symptoms, health-related quality of life, participation and health care satisfaction after ten years.

Authors:  Madelon B Bronner; Juanita A Haagsma; Manon L Dontje; Lotte Barmentloo; Rianne M C E J Kouwenberg; Alfons G M Olde Loohuis; Annemieke de Groot; Vicki Erasmus; Suzanne Polinder
Journal:  J Psychosom Res       Date:  2020-09-22       Impact factor: 3.006

8.  Whole Blood Interferon γ Release Is a More Sensitive Marker of Prior Exposure to Coxiella burnetii Than Are Antibody Responses.

Authors:  Anja Scholzen; Margot de Vries; Hans-Peter Duerr; Hendrik-Jan Roest; Ann E Sluder; Mark C Poznansky; Milou L C E Kouwijzer; Anja Garritsen
Journal:  Front Immunol       Date:  2021-07-28       Impact factor: 7.561

9.  Impact of Q-fever on physical and psychosocial functioning until 8 years after Coxiella burnetii infection: An integrative data analysis.

Authors:  Daphne F M Reukers; Cornelia H M van Jaarsveld; Reinier P Akkermans; Stephan P Keijmel; Gabriella Morroy; Adriana S G van Dam; Peter C Wever; Cornelia C H Wielders; Koos van der Velden; Joris A F van Loenhout; Jeannine L A Hautvast
Journal:  PLoS One       Date:  2022-02-02       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.